Natixis Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.6M | Buy |
116,975
+4,130
| +4% | +$379K | 0.01% | 663 |
|
|
2025
Q4 | $10.1M | Buy |
112,845
+16,210
| +17% | +$1.54M | 0.01% | 649 |
|
|
2025
Q3 | $9.52M | Buy |
96,635
+15,402
| +19% | +$1.53M | 0.01% | 676 |
|
|
2025
Q2 | $7.41M | Buy |
81,233
+4,931
| +6% | +$477K | 0.01% | 724 |
|
|
2025
Q1 | $8.64M | Buy |
76,302
+4,920
| +7% | +$526K | 0.02% | 682 |
|
|
2024
Q4 | $7.54M | Buy |
71,382
+7,731
| +12% | +$830K | 0.01% | 718 |
|
|
2024
Q3 | $6.87M | Buy |
63,651
+12,602
| +25% | +$1.38M | 0.01% | 748 |
|
|
2024
Q2 | $5.54M | Sell |
51,049
-15,673
| -23% | -$1.85M | 0.01% | 768 |
|
|
2024
Q1 | $8.81M | Sell |
66,722
-84,103
| -56% | -$10.5M | 0.02% | 644 |
|
|
2023
Q4 | $18.4M | Buy |
150,825
+6,204
| +4% | +$692K | 0.05% | 389 |
|
|
2023
Q3 | $16.2M | Sell |
144,621
-63,101
| -30% | -$8.01M | 0.05% | 379 |
|
|
2023
Q2 | $30.2M | Buy |
207,722
+27,586
| +15% | +$3.75M | 0.09% | 233 |
|
|
2023
Q1 | $23.3M | Buy |
180,136
+18,573
| +11% | +$2.33M | 0.08% | 261 |
|
|
2022
Q4 | $20.6M | Buy |
161,563
+41,645
| +35% | +$4.83M | 0.08% | 287 |
|
|
2022
Q3 | $12.5M | Buy |
119,918
+11,573
| +11% | +$1.27M | 0.05% | 379 |
|
|
2022
Q2 | $11.4M | Sell |
108,345
-62,013
| -36% | -$7.36M | 0.05% | 409 |
|
|
2022
Q1 | $21.8M | Buy |
170,358
+30,193
| +22% | +$3.64M | 0.08% | 261 |
|
|
2021
Q4 | $17.3M | Sell |
140,165
-13,501
| -9% | -$1.77M | 0.07% | 318 |
|
|
2021
Q3 | $21.8M | Sell |
153,666
-15,080
| -9% | -$2.22M | 0.09% | 232 |
|
|
2021
Q2 | $26.3M | Buy |
168,746
+50
| +0% | +$8.1K | 0.12% | 192 |
|
|
2021
Q1 | $26.2M | Buy |
168,696
+19,379
| +13% | +$3M | 0.14% | 181 |
|
|
2020
Q4 | $22.3M | Buy |
149,317
+22,829
| +18% | +$3.22M | 0.13% | 190 |
|
|
2020
Q3 | $16.7M | Sell |
126,488
-8,460
| -6% | -$1.11M | 0.11% | 221 |
|
|
2020
Q2 | $15.6M | Buy |
134,948
+10,741
| +9% | +$1.24M | 0.1% | 227 |
|
|
2020
Q1 | $12.2M | Buy |
124,207
+12,457
| +11% | +$1.63M | 0.1% | 232 |
|
|
2019
Q4 | $16.2M | Buy |
111,750
+3,850
| +4% | +$531K | 0.11% | 211 |
|
|
2019
Q3 | $14.4M | Buy |
107,900
+12,756
| +13% | +$1.65M | 0.11% | 208 |
|
|
2019
Q2 | $10.9M | Buy |
95,144
+12,702
| +15% | +$1.49M | 0.09% | 243 |
|
|
2019
Q1 | $10.2M | Sell |
82,442
-4,464
| -5% | -$507K | 0.09% | 254 |
|
|
2018
Q4 | $8.75M | Sell |
86,906
-3,385
| -4% | -$381K | 0.09% | 252 |
|
|
2018
Q3 | $11.5M | Buy |
90,291
+24,406
| +37% | +$2.9M | 0.1% | 222 |
|
|
2018
Q2 | $7.13M | Buy |
65,885
+11,757
| +22% | +$1.28M | 0.07% | 345 |
|
|
2018
Q1 | $5.73M | Buy |
54,128
+14,528
| +37% | +$1.69M | 0.06% | 390 |
|
|
2017
Q4 | $4.64M | Buy |
39,600
+2,744
| +7% | +$310K | 0.05% | 444 |
|
|
2017
Q3 | $4.19M | Sell |
36,856
-25,770
| -41% | -$2.97M | 0.04% | 486 |
|
|
2017
Q2 | $7.81M | Buy |
62,626
+6,468
| +12% | +$767K | 0.08% | 279 |
|
|
2017
Q1 | $6.66M | Buy |
56,158
+5,475
| +11% | +$621K | 0.07% | 335 |
|
|
2016
Q4 | $5.08M | Buy |
50,683
+1,903
| +4% | +$204K | 0.06% | 396 |
|
|
2016
Q3 | $6.16M | Sell |
48,780
-3,106
| -6% | -$384K | 0.08% | 312 |
|
|
2016
Q2 | $6.06M | Buy |
51,886
+6,461
| +14% | +$731K | 0.08% | 305 |
|
|
2016
Q1 | $4.7M | Buy |
45,425
+15,109
| +50% | +$1.46M | 0.07% | 362 |
|
|
2015
Q4 | $3.02M | Sell |
30,316
-126,045
| -81% | -$12.3M | 0.05% | 486 |
|
|
2015
Q3 | $14.3M | Buy |
156,361
+24,728
| +19% | +$2.48M | 0.25% | 78 |
|
|
2015
Q2 | $14M | Buy |
131,633
+3,544
| +3% | +$392K | 0.24% | 88 |
|
|
2015
Q1 | $14.6M | Buy |
128,089
+5,165
| +4% | +$589K | 0.26% | 77 |
|
|
2014
Q4 | $13.5M | Buy |
122,924
+12,150
| +11% | +$1.28M | 0.25% | 76 |
|
|
2014
Q3 | $10.8M | Sell |
110,774
-103,749
| -48% | -$10.2M | 0.22% | 100 |
|
|
2014
Q2 | $21.6M | Buy |
214,523
+7,600
| +4% | +$742K | 0.31% | 53 |
|
|
2014
Q1 | $19M | Sell |
206,923
-96,725
| -32% | -$8.91M | 0.29% | 62 |
|
|
2013
Q4 | $27.5M | Buy |
303,648
+24,079
| +9% | +$2.08M | 0.45% | 22 |
|
|
2013
Q3 | $22.3M | Buy |
279,569
+41,906
| +18% | +$3.3M | 0.41% | 29 |
|
|
2013
Q2 | $17.3M | Buy |
+237,663
| New | +$17.8M | 0.34% | 42 |
|
Other funds holding ZBH
VCM
VPM
Natixis Advisors's ZBH Position: Q1 2026 in Review
Natixis Advisors increased its Zimmer Biomet (ZBH) stake by 3.7% in Q1 2026, buying an estimated $379K and bringing the position to 116,975 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #663.
Natixis Advisors first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.2M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Natixis Advisors held 116,975 shares of Zimmer Biomet worth $10.6M as of Q1 2026.
- Natixis Advisors bought 4,130 Zimmer Biomet shares in Q1 2026, an estimated $379K.
- Zimmer Biomet made up 0.01% of Natixis Advisors's portfolio in Q1 2026, its #663 holding.
- Natixis Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Natixis Advisors's Zimmer Biomet position peaked at $30.2M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.